---
title: "IRB/IEC & Approvals"
---

## Approval Rules of Thumb (CRA Use)
- No site activity begins before IRB/IEC approval (per protocol and site requirements)
- All versions of protocol/ICF in use must be IRB/IEC-approved
- Continuing review approvals must remain current (if applicable)

## Approval Verification Workflow

```{mermaid}
flowchart LR
  A[Document Version Issued] --> B[IRB/IEC Review & Approval]
  B --> C[Site Implements Approved Version]
  C --> D[CRA Confirms Version Control at Visit]
  D --> E[File to Site Binder + TMF]
```

## CRA Monitoring Checks

- [ ] Current IRB approval covers current protocol version
- [ ] ICF version in use matches IRB approval letter
- [ ] Recruitment materials approved (if used)
- [ ] Continuing review dates tracked; no lapse occurred
- [ ] Local IRB requirements met (if multi-IRB environment)

::: {.callout-note title="Oncology-Specific Considerations"}
Safety updates and amendments are frequent â†’ approval tracking must be disciplined
:::

::: {.callout-note title="Vaccine Trial Considerations"}
Vaccine trials may operate under accelerated start-up timelines to support rapid enrollment.
Ensure IRB/IEC approvals, consent versions, recruitment materials, and protocol amendments
are fully documented and filed despite compressed activation schedules.
:::
